Drug profile · INN
prednisolone sodium phosphate
PREDMIX
prednisolone sodium phosphate (PREDMIX) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — prednisolone sodium phosphate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
prednisolone sodium phosphate (PREDMIX) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prednisolone sodium phosphate?
prednisolone sodium phosphate (PREDMIX) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for prednisolone sodium phosphate?
PREDMIX is a marketed brand name for prednisolone sodium phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prednisolone sodium phosphate?
prednisolone sodium phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.